Cancer risk from nitrosamine-contaminated valsartan | Drug and Therapeutics Bulletin

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Browse

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

DTB select

Cancer risk from nitrosamine-contaminated valsartan

Online download statistics by month:

Online download statistics by month: July 2021 to March 2024

	Abstract	Full	Pdf
Jul 2021	46	30	13
Aug 2021	45	10	7
Sep 2021	34	12	13
Oct 2021	389	27	18
Nov 2021	351	9	5
Dec 2021	341	8	9
Jan 2022	271	5	5
Feb 2022	95	0	1
Mar 2022	84	1	1
Apr 2022	168	6	6
May 2022	188	0	0
Jun 2022	275	4	3
Jul 2022	116	2	1
Aug 2022	150	0	0
Sep 2022	172	4	1
Oct 2022	178	1	1
Nov 2022	49	1	0
Dec 2022	53	0	0
Jan 2023	87	0	0
Feb 2023	80	0	0
Mar 2023	30	0	1
Apr 2023	35	0	0
May 2023	38	0	0
Jun 2023	39	1	0
Jul 2023	66	0	0
Aug 2023	25	2	0
Sep 2023	20	0	0
Oct 2023	16	0	0
Nov 2023	97	1	0
Dec 2023	68	2	0
Jan 2024	53	1	1
Feb 2024	70	0	0
Mar 2024	81	1	0
Total	3810	128	86